Regulation of collagenase activities of human cathepsins by glycosaminoglycans Z Li, Y Yasuda, W Li, M Bogyo, N Katz, RE Gordon, GB Fields, ... Journal of Biological Chemistry 279 (7), 5470-5479, 2004 | 295 | 2004 |
Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium WS Hou, W Li, G Keyszer, E Weber, R Levy, MJ Klein, EM Gravallese, ... Arthritis & Rheumatism 46 (3), 663-674, 2002 | 249 | 2002 |
Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis E Tolosa, W Li, Y Yasuda, W Wienhold, LK Denzin, A Lautwein, ... The Journal of clinical investigation 112 (4), 517-526, 2003 | 185 | 2003 |
YAP and the Hippo pathway in pediatric cancer AA Ahmed, AD Mohamed, M Gener, W Li, E Taboada Molecular & cellular oncology 4 (3), e1295127, 2017 | 62 | 2017 |
Srcasm inhibits Fyn-induced cutaneous carcinogenesis with modulation of Notch1 and p53 L Zhao, W Li, C Marshall, T Griffin, M Hanson, R Hick, T Dentchev, ... Cancer research 69 (24), 9439-9447, 2009 | 62 | 2009 |
The 5th Edition of the World Health Organization Classification of Hematolymphoid Tumors W Li Exon Publications, 1-21, 2022 | 57 | 2022 |
Srcasm modulates EGF and Src-kinase signaling in keratinocytes W Li, C Marshall, L Mei, L Dzubow, C Schmults, M Dans, J Seykora Journal of Biological Chemistry 280 (7), 6036-6046, 2005 | 56 | 2005 |
Activation of Src‐family tyrosine kinases in hyperproliferative epidermal disorders EE Ayli, W Li, TT Brown, A Witkiewicz, R Elenitsas, JT Seykora Journal of cutaneous pathology 35 (3), 273-277, 2008 | 52 | 2008 |
Two novel TP63 mutations associated with the ankyloblepharon, ectodermal defects, and cleft lip and palate syndrome: a skin fragility phenotype AS Payne, AC Yan, E Ilyas, W Li, JT Seykora, TL Young, BR Pawel, ... Archives of dermatology 141 (12), 1567-1573, 2005 | 52 | 2005 |
Inhibition of cathepsin K with lysosomotropic macromolecular inhibitors D Wang, M Pechar, W Li, P Kopecková, D Brömme, J Kopeček Biochemistry 41 (28), 8849-8859, 2002 | 49 | 2002 |
Cathepsin K inhibitor–polymer conjugates: potential drugs for the treatment of osteoporosis and rheumatoid arthritis D Wang, W Li, M Pechar, P Kopečková, D Brömme, J Kopeček International journal of pharmaceutics 277 (1-2), 73-79, 2004 | 47 | 2004 |
Srcasm corrects Fyn-induced epidermal hyperplasia by kinase down-regulation W Li, C Marshall, L Mei, J Gelfand, JT Seykora Journal of Biological Chemistry 282 (2), 1161-1169, 2007 | 39 | 2007 |
Normal or reactive minor cell populations in bone marrow and peripheral blood mimic minimal residual leukemia by flow cytometry W Li, R Morgan, R Nieder, S Truong, SSM Habeebu, AA Ahmed Cytometry Part B: Clinical Cytometry 100 (5), 590-601, 2021 | 24 | 2021 |
Curcuminoids activate p38 MAP kinases and promote UVB‐dependent signalling in keratinocytes EE Ayli, S Dugas‐Breit, W Li, C Marshall, L Zhao, M Meulener, T Griffin, ... Experimental dermatology 19 (6), 493-500, 2010 | 21 | 2010 |
Flow cytometry in the diagnosis of leukemias W Li | 17 | 2022 |
NUT midline carcinoma with leukemic presentation mimicking CD34-positive acute leukemia W Li, K Chastain Blood, The Journal of the American Society of Hematology 132 (4), 456-456, 2018 | 15 | 2018 |
Application of 2016 WHO classification in the diagnosis of paediatric high-grade MYC-negative mature B-cell lymphoma with Burkitt-like morphological features L Zhang, LE Brown, LM Bowen, LC McCarthy, LD Cooley, E Repnikova, ... Journal of clinical pathology 73 (9), 563-570, 2020 | 14 | 2020 |
Diagnosis of intrathyroidal ectopic thymus in thyroid fine needle aspiration samples W Li, D Dim, L Paulson, D Rivard Journal of clinical pathology 72 (2), 145-151, 2019 | 9 | 2019 |
Srcasm overexpression in psoriasis‐insights into pathogenesis M Pulitzer, W Li, M Hanson, F Singh, R Elenitsas, JM Gelfand, ... Journal of cutaneous pathology 34 (2), 160-165, 2007 | 9 | 2007 |
Measurable residual disease testing in acute leukemia: Technology and clinical significance W Li Exon Publications, 79-100, 2022 | 7 | 2022 |